Pituitary stalk lesions: The mayo clinic experience

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1812-1818

  Turcu, Adina F ^a   Erickson, Bradley J ^b   Lin, Eleanor ^c   Guadalix, Sonsoles ^d   Schwartz, Kara ^b   Scheithauer, Bernd W ^b   Atkinson, John L D ^a   Young, William F ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b Department of Radioogy ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GROWTH HORMONE; PROLACTIN; SOMATOMEDIN C;

ADENOHYPOPHYSIS HYPOFUNCTION; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; ASTROCYTOMA; CHILD; CONTRAST ENHANCEMENT; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; FEMALE; GERM CELL TUMOR; HUMAN; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROHYPOPHYSIS DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PITUITARY SALK LESION; PITUITARY STALK; PRESCHOOL CHILD; PRIORITY JOURNAL; SARCOIDOSIS; SCHOOL CHILD; VISUAL FIELD DEFECT;

EID: 84877716411     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4171     Document Type: Article

References (17)

1. Rupp D, Molitch M. Pituitary stalk lesions. Curr Opin Endocrinol Diabetes Obes. 2008;15:339-345.
2. Hamilton BE, Salzman KL, Osborn AG. Anatomic and pathologic spectrum of pituitary infundibulum lesions. AJR Am J Roentgenol. 2007;188:W223-232.
3. Trabelsi L, Mnif M, Rekik N, et al. MRI pituitary stalk abnormalities: etiology aspects in 11 patients [in French]. Ann Endocrinol (Paris). 2006;67:604-612.
4. Chen S, Leger J, Garel C, Hassan M, Czernichow P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab. 1999;84:2408-2413.
5. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am J Neuroradiol. 1990;11:915-923.
6. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis-diagnosis and management. QJM. 1999;92:103-117.
7. Bihan H, Christozova V, Dumas JL, et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore). 2007;86:259-268.
8. Caputo R, Veraldi S, Grimalt R, et al. The various clinical patterns of xanthoma disseminatum. Considerations on seven cases and review of the literature. Dermatology. 1995;190:19-24.
9. Hisanaga Y, Akaike Y, Kuroda K. Xanthoma disseminatum with large plaques confined to the back, pulmonary involvement and multiple intestinal xanthomas. Dermatology. 2004;208:164-166.
10. Pinto ME, Escalaya GR, Escalaya ME, Pinto JL, Chian CA. Xanthoma disseminatum: case report and literature review. Endocr Pract. 2010;16:1003-1006.
11. Oka M, Oniki S, Komatsu M, et al. Xanthoma disseminatum with intracranial involvement: case report and literature review. Int J Dermatol. 2010;49:193-199.
12. Fassett DR, Couldwell WT. Metastases to the pituitary gland. Neurosurg Focus. 2004;16:E8.
13. Schubiger O, Haller D. Metastases to the pituitary-hypothalamic axis. An MR study of 7 symptomatic patients. Neuroradiology. 1992;34:131-134.
14. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78: 1781-1788.
15. Heshmati HM, Scheithauer BW, Young WFJ. Metastases to the pituitary gland. Endocrinologist. 2002;12:45-49.
16. Teears RJ, Silverman EM. Clinicopathologic review of 88 cases of carcinoma metastatic to the pituitary gland. Cancer. 1975;36:216-220.
17. Morita A, Meyer FB, Laws ER Jr. Symptomatic pituitary metastases. J Neurosurg. 1998;89:69-73.